Alphabet Inc.'s Verily Life Sciences LLC is set to receive $800 million in funding from Temasek, a Singapore-based investment company. A majority of the investment will be funded in the coming days, and the remainder will come in the second half of this year. In exchange for the funding, Temasek will receive a minority stake in the Mountain View, Calif.-based company, which was once Google's life sciences division. Read More
